Inmune Bio adopts Third Amended and Restated 2021 Stock Incentive Plan
Inmune Bio Inc. has amended and restated its 2021 Stock Incentive Plan to provide equity awards to executives, employees, advisors and board members. The plan modification enables the company to continue incentivizing talent retention and aligning employee interests with long-term shareholder value creation.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day